ShareValue scores for RJF.MC: Valuation 54, Quality 39, Growth 28, Health 37.

Laboratorio Reig Jofre S.A logo

RJF.MC
BME

Laboratorio Reig Jofre S.A

€2.75(+0.36%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

2% to 16%
Valuation
54
Fair Value
Price vs Value
Quality
39
Weak
Business Strength
Growth
28
Weak
Revenue & Earnings
Health
37
Stressed
Financial Stability
Momentum
51
Neutral
Price Trend

Company Details

About

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026